investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Illuminating the Druggable Genome
Tudor Oprea
7 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Larry A Sklar
University of New Mexico
Albuquerque, United States
Stephen C Schurer
University of Miami
Coral Gables, United States
Anton M Simeonov
National Center for Advancing Translational Sciences (NIH)
Rockville, United States
John Overington
European Molecular Biology Laboratory
Heidelberg, Germany
Lars Juhl Jensen
Novo Nordisk (Denmark)
Copenhagen, Denmark
Soren Brunak
Novo Nordisk (Denmark)
Copenhagen, Denmark
Anne Hersey
European Bioinformatics Institute
Cambridge, United Kingdom
Tudor Oprea
University of New Mexico
Albuquerque, United States
Related projects
Gerald R. Crabtree
ATP-Dependent Chromatin Remodeling in Human Malignancy
All cancers but non-melanoma skin cancer
Giovanna Tosato
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
All cancers but non-melanoma skin cancer
Hematology and hematologic malignancies
Caroline Springer
Late Stage Lead Optimisation, Preclinical Development and Clinical Trial of Lysyl Oxidase (LOX) Inhibitors
All cancers but non-melanoma skin cancer
George Pavlakis
DNA Vaccines
All cancers but non-melanoma skin cancer
Pathology
Carl D Novina
Analysis of cap-dependent translational repression by microRNAs in oncogenisis
All cancers but non-melanoma skin cancer
Edward Seto
The Basic and Translational Implication of SIRT1 and DNMT1 in Cancer
All cancers but non-melanoma skin cancer
Katsonuri Sugimoto
Surveillance and Maintenance of DNA Ends
All cancers but non-melanoma skin cancer
Eric Daniel Olmon
Examining the Kinetics of Base Excision Repair in the Context of Chromatin
All cancers but non-melanoma skin cancer
Nelson Chao
Expanding cancer care in the lake region of Tanzania
All cancers but non-melanoma skin cancer
